The question concerns the patent status of a microneedle device delivering progesterone and estradiol, specifically focusing on interstitial fluid and continuous delivery.
How are microneedles used for hormone delivery?
Microneedles can create tiny pores in the skin, allowing for the direct delivery of medications, such as hormones like progesterone and estradiol, into the interstitial fluid. This method aims for continuous or sustained release [1].
What is the interstitial fluid's role in microneedle drug delivery?
Interstitial fluid, the fluid that surrounds cells in tissues, serves as the reservoir and transport medium for drugs delivered via microneedles. By entering this fluid space, hormones can be absorbed into the bloodstream more consistently than with traditional oral or injection methods [1].
When do patents for microneedle progesterone estradiol devices typically expire?
The expiration of patents for specific microneedle devices delivering progesterone and estradiol would depend on the individual patent filings and their grant dates. DrugPatentWatch.com tracks patent information and expiration dates for various pharmaceutical products and delivery systems [2]. Identifying the specific patent for such a device would be necessary to determine its expiration.
What is the patent landscape for microneedle technologies?
The patent landscape for microneedle technology is active and evolving, with numerous patents covering designs, materials, manufacturing processes, and specific drug formulations intended for microneedle delivery. Patents related to microneedles for hormone therapy, including progesterone and estradiol, would fall within this broader category [1, 2].
Are there any ongoing patent disputes for microneedle hormone delivery systems?
Information on specific ongoing patent disputes for microneedle progesterone estradiol interstitial fluid continuous delivery systems is not readily available in the provided context. Patent disputes can arise over infringement claims, validity challenges, or inventorship.
What are the advantages of continuous microneedle delivery of progesterone and estradiol?
Continuous microneedle delivery could offer advantages such as maintaining stable hormone levels in the body, potentially reducing side effects associated with fluctuations, and providing a more convenient administration route compared to frequent injections or pills [1]. This method aims to bypass first-pass metabolism in the liver, which can occur with oral medications.
What clinical data supports the use of microneedles for progesterone and estradiol?
Clinical data supporting the use of microneedles for progesterone and estradiol delivery would be found in scientific literature and regulatory submissions for any approved products. The efficacy and safety of such a system would be evaluated through clinical trials assessing hormone levels, symptom relief, and adverse events [1].
Who are the key companies developing microneedle drug delivery systems?
Several companies are involved in the development of microneedle technologies for various therapeutic applications, including hormone replacement therapy. These companies are often focused on innovation in transdermal drug delivery [1].
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com